Maria Martin Lopes
Cresskill, NJNPI 1093969784
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $569,213 of the $775,877 with a category attached, or 73.4%. It is spread thinly across 57 manufacturers, the largest accounting for just 20.8%.
Across 659 payments — averaging $1177.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$161K
- Pfizer$101K
- Sanofi$70K
- EMD Serono, Inc.$51K
- Medtronic$49K
- Boehringer Ingelheim$33K
- plus $309K from 51 others
What the payments were for
- Consulting fees$569,21373%
- Speaking & faculty fees$117,92115%
- Travel & lodging$73,83210%
- Food & beverage$14,9122%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.